|
|
|
|
Nasopharyngeal Cancer
International Approvals: Procoralan, H101, AP2573 Nov 21, 2005
Medscape (subscription) ...and Drug Administration has approved an oncolytic adenovirus for use with chemotherapy in the treatment of late-stage refractory nasopharyngeal cancer; and the ...
'I'm kind of like Job' Aug 20, 2005
And yet, the determined young woman fought through life-threatening treatments and radiation to force her disease, Nasopharyngeal cancer, into remission. ... Norman Transcript,
YM BioSciences to present results of Norelin(TM) study at Cancer ... Sep 5, 2005
...an anti-EGFr humanized monoclonal antibody for which Phase II clinical data were released in 2005 in pediatric glioma and nasopharyngeal cancer, and for which ... CNW Telbec (Communiqués de presse),
YM BioSciences to Initiate Non-Small-Cell Lung Cancer Trial with ... Aug 17, 2005
..."A randomized trial with nimotuzumab that included 130 patients suffering from nasopharyngeal cancer was recently completed in China and demonstrated the ... Yahoo News (press release)
YM BioSciences reports 2005 year end operational and financial ... -- Sep 12, 2005
...an anti-EGFr humanized monoclonal antibody for which Phase II clinical data were released in 2005 in pediatric glioma and nasopharyngeal cancer, and for which ... / Yahoo! News (press release)
'I'm kind of like Job' -- Aug 20, 2005
And yet, the determined young woman fought through life-threatening treatments and radiation to force her disease, Nasopharyngeal cancer, into remission. ... / Norman Transcript,
YM BioSciences to Initiate Non-Small-Cell Lung Cancer Trial with ... -- Aug 17, 2005
..."A randomized trial with nimotuzumab that included 130 patients suffering from nasopharyngeal cancer was recently completed in China and demonstrated the ... / Yahoo News (press release)
'I'm kind of like Job' Aug 20, 2005
And yet, the determined young woman fought through life-threatening treatments and radiation to force her disease, Nasopharyngeal cancer, into remission. ... Norman Transcript,
YM BioSciences to present results of Norelin(TM) study at Cancer ... Sep 5, 2005
...an anti-EGFr humanized monoclonal antibody for which Phase II clinical data were released in 2005 in pediatric glioma and nasopharyngeal cancer, and for which ... CNW Telbec (Communiqués de presse),
YM BioSciences to Initiate Non-Small-Cell Lung Cancer Trial with ... Aug 17, 2005
..."A randomized trial with nimotuzumab that included 130 patients suffering from nasopharyngeal cancer was recently completed in China and demonstrated the ... Yahoo News (press release)
Sabah nose cancer cases -- Jul 8, 2005
Kota Kinabalu: A Queen Elizabeth Hospital (QEH) study showed that the majority of nasopharyngeal cancer patients in Sabah were Kadazan at 58 per cent, followed ... / Daily Express,
YM BioSciences Expands Development Program for EGFR Inhibitor ... -- Jun 15, 2005
...hR3, an EGFr humanized monoclonal antibody on which Phase II clinical data have recently been released in pediatric glioma and nasopharyngeal cancer, and for ... / PharmaLive.com (press release),
Varian Medical Systems Receives FDA 510(k) Clearance for New ... -- Mar 14, 2005
...that the company has received FDA 510(k) clearance for a brachytherapy solution that enables more accurate and flexible treatment of nasopharyngeal cancer. ... / PR Newswire (press release)
A day for diabetes in the desert -- Mar 8, 2005
A member of the herpes family, Epstein-Barr virus is responsible for mononucleosis and commonly associated with nasopharyngeal cancer tumors. ... / Press-Enterprise (subscription),
EBV-Specific T Cells Show Promise as Treatment for Nasopharyngeal ... -- Mar 1, 2005
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes appears to be a safe, potentially effective, therapy for nasopharyngeal cancer, according to a report ... / Cancerpage.com,
YM BioSciences reports second quarter 2005 operational and ... -- Feb 11, 2005
YM's licensor, CIMAB, reported a 90.6% complete response from a randomized Phase II pivotal nasopharyngeal cancer trial using TheraCIM h-R3 in combination ... / Yahoo News (press release)
YM BioSciences reports second quarter 2005 operational and ... -- Feb 11, 2005
...h-R3, an EGFr humanized monoclonal antibody on which Phase II clinical data have recently been released in pediatric glioma and nasopharyngeal cancer, and for ... / PharmaLive.com (press release),
Varian Medical Systems Receives FDA 510(k) Clearance for New ... Mar 14, 2005
...that the company has received FDA 510(k) clearance for a brachytherapy solution that enables more accurate and flexible treatment of nasopharyngeal cancer. ... PR Newswire
A day for diabetes in the desert Mar 8, 2005
A member of the herpes family, Epstein-Barr virus is responsible for mononucleosis and commonly associated with nasopharyngeal cancer tumors. ... Press-Enterprise (subscription)
EBV-Specific T Cells Show Promise as Treatment for Nasopharyngeal ... Mar 1, 2005
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes appears to be a safe, potentially effective, therapy for nasopharyngeal cancer, according to a report ... Cancerpage.com
YM BioSciences reports second quarter 2005 operational and ... Feb 11, 2005
YM's licensor, CIMAB, reported a 90.6% complete response from a randomized Phase II pivotal nasopharyngeal cancer trial using TheraCIM h-R3 in combination ... Yahoo News
YM BioSciences reports second quarter 2005 operational and ... Feb 11, 2005
...h-R3, an EGFr humanized monoclonal antibody on which Phase II clinical data have recently been released in pediatric glioma and nasopharyngeal cancer, and for ... PharmaLive.com
Addition of Brachytherapy to Chemotherapy and Radiation Provides ... May 23, 2004
...of brachytherapy to chemotherapy and radiation therapy provides high anti-cancer response rates for patients with locally advanced nasopharyngeal cancer. ... Cancer Consultants
New way to gauge tumours more accurately May 11, 2004
Another on nasopharyngeal cancer will be published next month in Radiology. Both are US publications. The team hopes to market the program to doctors. ... Straits Times
Hmong face high rates of some cancers -- Oct 22, 2004
Nasopharyngeal cancer was diagnosed early in only 3 percent of cases, stomach cancer in only 10 percent of cases and liver cancer in only 15 percent. ... / Medical News Today,
Cancer leading cause of death for state's Asian-American women -- Oct 23, 2004
...liver cancer. Nasopharyngeal cancer is associated with several risk factors, including consumption of Cantonese salted fish. Stomach ... / San Jose Mercury News (subscription),
Medical School lands grant of $7.5 million -- Oct 5, 2004
This virus makes small RNAs in the latent stage of the infection process and is associated with Burkitt's lymphoma and nasopharyngeal cancer. ... / Yale Daily News
Researching the health of former timber workers -- Sep 5, 2004
These include: research on occupational causes of bladder cancer, leukaemia, non-Hodgkin’s lymphoma and nasopharyngeal cancer; studies of cancer in workers ... / Massey News,
Formaldehyde could cause throat cancer -- Aug 25, 2004
...the International Agency for Research on Cancer, part of the World Health Organisation, concluded that formaldehyde causes nasopharyngeal cancer, a relatively ... / Plastics & Rubber Weekly,
Aggressive treatment for nasopharyngeal cancer shown to be more ... -- Aug 9, 2004
Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of ... / News-Medical.net, World -
Aggressive treatment achieves results in nasopharyngeal cancer -- Aug 9, 2004
A regime of radiotherapy and concurrent chemotherapy is proving successful in the treatment of nasopharyngeal cancer. Radiotherapy ... / HealthandAge.com -
Hodgkin's lymphoma said linked to measles virus -- Aug 9, 2004
...cervical cancer, which can be caused by the papilloma virus; liver cancer, which can be caused by the hepatitis B virus; and nasopharyngeal cancer, which can ... / Jerusalem Post (subscription), Israel -
Combo treatment for cancer saves more lives -- Jul 30, 2004
It led to speculation that American patients suffering from nasopharyngeal cancer, which affects the back of the nose, are different from Asian sufferers. ... / Straits Times, Singapore -
The Oklahoman -- Jul 24, 2004
...for Amandalynn Riggs, who, at 15, found herself pregnant while simultaneously receiving treatment for a rare form of nasal cancer, called nasopharyngeal cancer ... / NewsOK.com (subscription), OK -
|
|
|
